Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about OrbiMed Backs China's Zai Lab In A $100M B Round
Venture Capital

OrbiMed Backs China's Zai Lab In A $100M B Round

by fiercebiotech.com posted 2years ago 7573 views
Shanghai-headquartered drug developer Zai Lab said it locked up more than $100 million in Series B financing, raising cash from a syndicate including OrbiMed and Sequoia Capital.